Valuation: Illumina, Inc.

Market Cap 29.12B 25.23B 23.62B 21.55B 40.56B 2,777B 41.24B 277B 109B 1,390B 109B 107B 4,638B P/E 2026 *
39x
P/E 2027 * 33x
Enterprise Value 29.36B 25.45B 23.82B 21.74B 40.9B 2,801B 41.59B 279B 109B 1,402B 110B 108B 4,677B EV / Sales 2026 *
6.35x
EV / Sales 2027 * 5.78x
Free-Float
74.97%
Yield 2026 *
-
Yield 2027 * -
1 day+0.55%
1 week-5.01%
Current month-5.98%
1 month+1.39%
3 months+35.32%
6 months+65.70%
Current year+47.03%
1 week 186.64
Extreme 186.64
196.73
1 month 178.88
Extreme 178.88
207
Current year 112.65
Extreme 112.65
207
1 year 88
Extreme 88
207
3 years 68.7
Extreme 68.7
207
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap.
8/5/26
Corvex Management LP
SellCompany -283,269 0.1872%
8/5/26 Free

Executive/Senior Manager

15,011 0.0099%
8/4/26 Other

Director

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+0.55%-5.01%+103.46%+6.85% 28.96B
+0.89%+7.13%+30.84%+11.26% 222B
-0.92%+6.50%+3.84%-18.78% 147B
+2.00%+8.95%-14.97%+31.77% 139B
+1.45%+4.28%-50.18%+0.31% 73.13B
+1.77%+4.53%+19.83%+17.94% 53.05B
+1.07%+1.51%-13.73%-16.11% 50.36B
+0.52%+7.39%+30.98%+17.84% 42B
+0.78%+4.78%+48.59%+42.29% 40.43B
-0.26%+3.54%-0.34%+1.62% 32.95B
Average +0.78%+217.57%+15.83%+9.50% 82.88B
Weighted average by Cap. +0.79%+308.27%+9.97%+8.47%

Financials

2026 *2027 *
Net sales 4.62B 4.01B 3.75B 3.42B 6.44B 441B 6.55B 43.99B 17.24B 221B 17.36B 16.99B 737B 4.91B 4.26B 3.98B 3.64B 6.84B 468B 6.96B 46.72B 18.3B 234B 18.44B 18.04B 782B
Net income 760M 659M 617M 563M 1.06B 72.52B 1.08B 7.23B 2.83B 36.3B 2.85B 2.79B 121B 891M 772M 723M 660M 1.24B 85.01B 1.26B 8.48B 3.32B 42.55B 3.35B 3.27B 142B
Net Debt 246M 213M 200M 182M 343M 23.47B 348M 2.34B 917M 11.75B 924M 904M 39.18B -729M -632M -591M -540M -1.02B -69.53B -1.03B -6.93B -2.72B -34.8B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-08-11 $192.84 +0.55% 867,974
26-08-10 $191.79 +2.04% 1,687,721
26-08-07 $187.96 -2.97% 1,825,259
26-08-06 $193.72 -3.08% 4,276,169
26-08-05 $199.87 -1.55% 2,266,096
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
192.84USD
Average target price
198.89USD
Spread / Average Target
+3.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock